Golden Developin Stock Price, News & Analysis

Golden Developing Solutions, Inc. (DVLP) has successfully completed its first acquisition, marking a significant milestone in its growth strategy within the Health and Wellness sector. This acquisition is part one of two in a planned transaction. CEO Stavros Triant expressed enthusiasm about the integration of the new team, emphasizing their alignment with the company's culture. The firm aims to leverage this acquisition for future developments, and updates are expected shortly. Investors are advised to stay informed through the company's communications.

Golden Developing Solutions Inc. (OTC Pink:DVLP) has announced its second set of acquisitions in the specialty pharmacy sector, with expected annual revenues of $60-65 million. The deal is set to close on November 4th, aiming to enhance the company's growth trajectory in the health and wellness industry. The acquisitions are described as profitable, scalable, and positioned for high revenue generation with low overhead costs. CEO Stavros Triant expressed optimism about completing the company’s roadmap for 2022.

Golden Developing Solutions Inc. (DVLP) announced a significant milestone with its first acquisition in the pharmaceuticals sector, projected to generate annual revenues of $22-24 million. The transaction is expected to close within 10 days and did not involve the issuance of restricted shares. CEO Stavros Triant expressed confidence in the company's growth trajectory as they move into the fourth quarter. The acquisition highlights include high profitability, scalability across the USA, and low overhead costs, supporting a growing customer base amidst increasing demand.

Golden Developing Solutions Inc. (OTC Pink: DVLP) announced significant updates regarding its acquisitions in the Health and Wellness marketplace. The company executed a Letter of Intent (LOI) to acquire assets expected to generate over $60 million in annual sales. A previous LOI was canceled due to insufficient profitability assurance. The company is working on three other acquisitions; one is projected to bring in approximately $12 million, another $25 million, and the third is undergoing preliminary tests. Their business pipeline remains strong.

Golden Developing Solutions Inc. (OTC PINK:DVLP) has signed a Letter of Intent (LOI) for a merger with a company generating approximately $10.5 million in annual revenue and an estimated EBITDA of $900,000. This acquisition aligns with DVLP's growing Telehealth platform and is one of several potential deals in the pipeline. The company is currently in the launch phase of its telemedicine network and is pursuing further acquisition targets. Additional details are expected soon.

Golden Developing Solutions (OTC PINK:DVLP) announced the launch of its telehealth subsidiary, Renown RX, aimed at enhancing access to prescription drugs. This initiative addresses ongoing challenges in securing timely doctor appointments, which can take weeks in some areas. Renown RX offers 24/7 consultations with licensed physicians across all 50 states and includes the dispensing of medications through 39 pharmacies. The telehealth market is projected to grow to $63 billion by 2027, positioning Renown RX as a potential leader in this expanding sector.

Golden Developing Solutions Inc. (OTC PINK:DVLP) has announced significant updates following a year of efforts to achieve Pink Current, fully reporting status. As of December 15, 2021, the recent dilution has been completed, confirmed by both the note holder and the transfer agent. The company has reduced Authorized Shares by 1.5 billion, and further negotiations on reducing Outstanding Shares are underway. DVLP plans to announce new ventures and acquisitions within 90 days while ensuring no reverse splits at current price levels to preserve shareholder value.